Clinical ResearchLatest news
News from our clinical trials in Orlando
Updates from Orlando Immunology Center: studies now enrolling, conference presentations and research milestones.
-
OIC Research in Orlando Explores Twice-Yearly HIV Treatment Through DAYBREAK Studies
OIC Research in Orlando is enrolling for DAYBREAK 1 and 2, Phase 3 studies of a complete HIV-1 treatment regimen given every six months.…
-
OIC Prepares to Launch Its First Influenza Study
Orlando Immunology Center begins enrollment this September for its first-ever influenza clinical study, a new area of research for our team. The study evaluates…
-
Dr. Rolle Featured in TheBodyPro on Advancing Diverse Clinical Trials
Charlotte-Paige Rolle, M.D., M.P.H., Director of Research Operations at Orlando Immunology Center, was featured in TheBodyPro discussing her work leading clinical trials at one…
-
OIC Presents at CROI 2026
Dr. Charlotte-Paige Rolle, Director of Research Operations at Orlando Immunology Center, presented updated results from the EMBRACE trial at CROI 2026 (Conference on Retroviruses…
-
New Once-Monthly Oral PrEP Study Now Enrolling
Orlando Immunology Center has begun enrollment for EXPRESSIVE (MK8527-011), a Phase 3 clinical trial evaluating MK-8527, an investigational oral tablet taken once a month…